Sustainability

Society

Human Rights

At Hisamitsu Pharmaceutical, not only do we comply with the laws and regulations of various countries and regions, but we also respect human rights and recognize our responsibilities to conduct business operations that will contribute to society. We perform human rights due diligence on a continual basis and respect the human rights of people all over the world, thereby contributing to the development of a sustainable society and the sustainability of the entire globe.

Basic Concept on Human Rights

Hisamitsu Pharmaceutical established the Hisamitsu Pharmaceutical Human Rights Policy in March 2018 based on the United Nations Guiding Principles on Business and Human Rights. We respect human rights as proclaimed in the United Nations International Bill of Human Rights (Universal Declaration of Human Rights, International Covenant on Civil and Political Rights, and International Covenant on Economic, Social and Cultural Rights), which stipulate fundamental human rights for all people, the core labor standards in the International Labour Organization's (ILO) Declaration on Fundamental Principles and Rights at Work, which stipulates fundamental rights at work, and the World Medical Association's Declaration of Helsinki (hereinafter collectively referred to as “international human rights principles”). These human rights are to be protected and respected by all officers and employees of the Company and its business partners, as well as by all people associated with the Company's products and services. To ensure that the human rights of these people are respected, the Company shall avoid causing or encouraging negative impacts on human rights, and take action if such negative impacts are evident. It is also our aim to prevent or mitigate negative impacts on human rights that are directly linked to the Company's business, products, and services through our business transactions.
This Policy is intended to incorporate the contents of the Hisamitsu Corporate Charter, which defines the Company's basic approach to respect for human rights, into our business activities in a more concrete manner. To ensure that the Policy is understood and effectively carried out, the Company will continue to provide appropriate education and training to all officers and employees.

Executing our obligations for human rights

Conduct of human rights due diligence In order to fulfill our obligations to respect human rights, Hisamitsu Pharmaceutical will conduct ongoing human rights due diligence targeting negative human rights impacts related to our business activities.
Dialog and consultation with stakeholders Hisamitsu Pharmaceutical will engage in meaningful dialog and consultation with its stakeholders, drawing on the knowledge of outside experts and others in the field of human rights.
Structure and responsible persons Hisamitsu Pharmaceutical will establish a system necessary to execute this Policy and clarify who is responsible and take appropriate measures considering the results of the assessment of negative impacts on human rights.
Correction Hisamitsu shall, if it becomes clear that we have caused or encouraged negative impacts on human rights, work to correct such impacts through appropriate means.
Information disclosure Hisamitsu Pharmaceutical shall monitor the conduct of corrective actions and disclose the status of promotion of these efforts, etc. on a regular basis.
Applicable laws and ordinances Hisamitsu Pharmaceutical complies with applicable laws and ordinances in each country and region where it operates, provided, however, that if there is any conflict between the laws and regulations of each country/region and the principles of international human rights, we shall pursue methods that fully respect the principles of international human rights.

Hisamitsu Pharmaceutical Human Rights Policy

Compliance with UK Modern Slavery Act

Statement on the UK Modern Slavery Act is available on our website.
Hisamitsu Pharmaceutical is committed to respecting internationally recognized human rights, including the prevention of slavery and human trafficking in our business and supply chain.

UK Modern Slavery Act Statement

Sustainability Procurement

From FY2021, we conduct the Self-Assessment Questionnaire (SAQ) every year with our primary and secondary suppliers of our products manufactured at factories in Japan to confirm the current status and assess risks with regard to human rights and labor, safety and health, environment, and compliance. In FY2022, we also started SAQ for primary and secondary suppliers of products manufactured at the factory in Hisamitsu Indonesia. In the future, we plan to assess the human rights risks of suppliers at other overseas subsidiaries as well.

Sustainable Procurement Guidelines

Halal Certified

Hisamitsu Pharmaceutical operates businesses in Indonesia, Malaysia, and other countries and regions where many Muslims live. To ensure that Muslims can use our products with peace of mind, we have established a Halal team within the Company and are promoting the creation of products that consider religion and the lifestyle of each country and region.
*Halal: What is legal under Islamic law

Launched on January 14, 2022, Indonesia
Launched on January 14, 2022, Indonesia

PAGETOP